Sign in

NCT07718880Completed

Nephroprotective Effects of Fig (Ficus Carica L.) Leaf Supplementation

Nephroprotective Effects of Fig (Ficus Carica L.) Leaf Supplementation in Grade II Chronic Kidney Disease

Source: ClinicalTrials.gov · Last updated 22 Jul 2026

Brief summary (registry, in English)

Diabetic nephropathy is the result of diabetes complications. Excessive blood glucose levels affect several organs which include liver, heart, and kidneys.The aim of this study is to use the nephroprotective and metabolic effects of fig (Ficus carica L.) leaf supplementation with a low glycemic index diet in grade-II chronic kidney disease patients.

Status (registry)
Completed
Study type
Interventional
Enrollment
60 (actual)
First submitted
14 Jul 2026
Start date
18 Sept 2025
Primary completion date
18 Nov 2025
Lead sponsor
University of Lahore
NCT number
NCT07718880

What you commit to

  • Study type: Interventional
  • Participants enrolled: 60
  • From 18 Sept 2025 to the primary completion date, 18 Nov 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study design.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Individuals that use insulin therapy apart from medication

Other illness

  • Allergic to latex or figs.

Other

  • Pregnant and lactating women
  • Severe complications like diabetic ketoacidosis
  • Individuals with highly restricted diets

Who the study is looking for

  • People within the age range of 35-65 years old adults (both genders)
  • Individuals diagnosed with Type 2 diabetes with an HbA1c level between 7-13%
  • Diabetics that consume oral hypoglycemic medication
  • Participants must have a BMI between 25kg/m2 and 39.9kg/m2

Age in the registry: 35 years to 65 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Save your city in your profile to sort them by distance.

SiteCityCountrySite status
The University of Lahore
Coordinator of this site? Confirm its status
LahorePakistanUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.